Linda May Green v CT Group Holdings Limited
[2023] EWHC 3168 (Comm)
Norwich Pharmacal relief requirements: (i) good arguable case of legally recognised wrong; (ii) respondent mixed up in facilitating wrongdoing; (iii) respondent able to provide necessary information; (iv) disclosure proportionate and appropriate.
Collier v Bennett [2020] 4 WLR 116 at [35]; Stanford Asset Holdings Ltd v AfrAsia Bank Ltd [2023] UKPC 35 at [36]
Litigation privilege attaches to communications, not facts or information. Disclosure of identity is only privileged if it inhibits candid discussion between lawyer and client.
Three Rivers (No 6) [2005] 1 AC 610; Loreley Financial v Credit Suisse Securities (Europe) Ltd [2023] 1 WLR 1425
In malicious falsehood claims, financial loss is presumed, and nominal damages are awarded if no loss is proven.
Section 3(1) of the Defamation Act 1952; George v Cannell [2024] UKSC 19
Norwich Pharmacal relief granted.
The court found a strong arguable case of forgery and wrongdoing, QE's involvement in facilitating the use of the report, and the necessity of disclosure to identify the wrongdoer. Litigation privilege did not apply to the Consultancy's identity.
[2023] EWHC 3168 (Comm)
[2024] EWHC 2527 (Comm)
[2024] EWHC 953 (TCC)
[2024] EWHC 1314 (Comm)
[2023] EWHC 425 (KB)